Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vidaza in Advanced Metastatic Prostate Cancer
NCT00384839Phase 2Completed
- Sponsor
- US Oncology Network
- Start
- Apr 2006
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azacitidine in prostate cancer (PCa), sponsored by US Oncology Network. Primary endpoint: Percentage of Patients With PSA Doubling Time >=3 Months. Started Apr 2006; status: completed.
02
Drugs
azacitidine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00384839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384839.